Is there a problem with oral corticosteroid use in asthma?

G. Brusselle (Ghent, Belgium)

Source: Virtual Congress 2020 – Airway diseases
Session: Airway diseases
Session type: State of the art session
Number: 4513
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Brusselle (Ghent, Belgium). Is there a problem with oral corticosteroid use in asthma?. Virtual Congress 2020 – Airway diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
How can we minimise the use of regular oral corticosteroids in asthma?
Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019
Year: 2020

Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020

What is the role of oral corticosteroids in the era of biologics in asthma?
Source: International Congress 2019 – State of the art session: Airway disease
Year: 2019

Oral corticosteroid prescription in asthma: Swiss situation
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020

How effective are oral steroids in asthma action plans?
Source: International Congress 2017 – Asthma management
Year: 2017

Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002

Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009

Oral corticosteroids for asthma usually prescribed by non-specialists
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020

Is beta-agonist alone prescribed in case of uncontrolled asthma?
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

Rescue/acute and allergy medication use among children on asthma controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 378s
Year: 2004

Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019

High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs
Source: Eur Respir J 2012; 40: 1072-1074
Year: 2012

Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
Source: Eur Respir J 2005; 26: Suppl. 49, 277s
Year: 2005

Asthma control and medication use five years after early or delayed introduction of inhaled corticosteroids in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003

It does matter which inhalative corticosteroids asthmatic patient use! Looking at ICS side effects from users perspective
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes
Source: Eur Respir J 2005; 26: Suppl. 49, 159s
Year: 2005

What to use INSTEAD of inhaled corticosteroids in COPD?
Source: Eur Respir J 2014; 44: 1391-1393
Year: 2014

Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Oral corticosteroid prescription patterns in asthma care in Italy
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019

Suppression of FENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019
Year: 2019